학술논문

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
Document Type
article
Source
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2051-1426